Current and historical daily PE Ratio for TOWA Pharmaceutical Co Ltd (
TSE:4553
) from 2004 to Jun 02 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. TOWA Pharmaceutical stock (TSE:4553) PE ratio as of Jun 02 2024 is 8.8.
More Details
TOWA Pharmaceutical Co Ltd (TSE:4553) PE Ratio (TTM) Chart
TOWA Pharmaceutical Co Ltd (TSE:4553) PE Ratio (TTM) Historical Data
View and export this data going back to 2004. Start your Free Trial
Total 1244
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| TOWA Pharmaceutical PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-02 | 8.8 | 2024-03-27 | 12.6 |
| 2024-05-31 | 8.8 | 2024-03-26 | 12.4 |
| 2024-05-30 | 8.6 | 2024-03-25 | 12.2 |
| 2024-05-29 | 8.7 | 2024-03-22 | 12.3 |
| 2024-05-28 | 8.8 | 2024-03-21 | 12.5 |
| 2024-05-27 | 8.7 | 2024-03-19 | 12.2 |
| 2024-05-24 | 8.6 | 2024-03-18 | 12.0 |
| 2024-05-23 | 8.6 | 2024-03-15 | 11.9 |
| 2024-05-22 | 8.2 | 2024-03-14 | 11.9 |
| 2024-05-21 | 8.3 | 2024-03-13 | 12.1 |
| 2024-05-20 | 8.3 | 2024-03-12 | 12.2 |
| 2024-05-17 | 8.3 | 2024-03-11 | 12.2 |
| 2024-05-16 | 8.1 | 2024-03-08 | 12.0 |
| 2024-05-15 | 8.3 | 2024-03-07 | 11.9 |
| 2024-05-14 | 8.7 | 2024-03-06 | 11.7 |
| 2024-05-13 | 8.4 | 2024-03-05 | 11.8 |
| 2024-05-10 | 8.4 | 2024-03-04 | 11.5 |
| 2024-05-09 | 8.3 | 2024-03-01 | 11.5 |
| 2024-05-08 | 8.3 | 2024-02-29 | 11.7 |
| 2024-05-07 | 8.5 | 2024-02-28 | 11.7 |
| 2024-05-02 | 8.5 | 2024-02-27 | 11.9 |
| 2024-05-01 | 8.5 | 2024-02-26 | 12.1 |
| 2024-04-30 | 8.6 | 2024-02-22 | 12.3 |
| 2024-04-26 | 8.4 | 2024-02-21 | 12.6 |
| 2024-04-25 | 8.4 | 2024-02-20 | 12.6 |
| 2024-04-24 | 8.5 | 2024-02-19 | 12.9 |
| 2024-04-23 | 8.5 | 2024-02-16 | 12.4 |
| 2024-04-22 | 8.5 | 2024-02-15 | 12.4 |
| 2024-04-19 | 8.4 | 2024-02-14 | 13.4 |
| 2024-04-18 | 8.5 | 2024-02-13 | 11.3 |
| 2024-04-17 | 8.4 | 2024-02-09 | 11.1 |
| 2024-04-16 | 8.4 | 2024-02-08 | 11.3 |
| 2024-04-15 | 8.5 | 2024-02-07 | 11.2 |
| 2024-04-12 | 8.6 | 2024-02-06 | 11.0 |
| 2024-04-11 | 8.4 | 2024-02-05 | 11.2 |
| 2024-04-10 | 8.5 | 2024-02-02 | 11.1 |
| 2024-04-09 | 8.4 | 2024-02-01 | 11.0 |
| 2024-04-08 | 8.4 | 2024-01-31 | 10.8 |
| 2024-04-05 | 8.3 | 2024-01-30 | 10.8 |
| 2024-04-04 | 8.4 | 2024-01-29 | 10.8 |
| 2024-04-03 | 8.4 | 2024-01-26 | 10.4 |
| 2024-04-02 | 8.4 | 2024-01-25 | 10.5 |
| 2024-04-01 | 8.6 | 2024-01-24 | 10.7 |
| 2024-03-29 | 8.8 | 2024-01-23 | 10.8 |
| 2024-03-28 | 8.9 | 2024-01-22 | 10.8 |
TOWA Pharmaceutical Co Ltd (TSE:4553) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
TOWA Pharmaceutical Co Ltd
NAICS : 325412
SIC : 2834
ISIN : JP3623150004
Share Class Description:
TSE:4553: Ordinary SharesCompare
Compare
Traded in other countries / regions
4553.Japan6QC.GermanyTWAPF.USA IPO Date
2004-04-05Description
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers